DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Spironolactone (Spironolactone) - Hypotension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypotension (41)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Spironolactone where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 41   Next >>

Possible Spironolactone side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-24

Patient: male

Reactions: Malaise, Dyspnoea, Hyperkalaemia, Hypotension, Bradycardia, Renal Failure Chronic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atacand
    Dosage: 8 mg
    Administration route: Oral
    Indication: Hypertensive Heart Disease
    End date: 2012-06-21

Nebivolol
    Dosage: 2.5 mg
    Administration route: Oral
    Indication: Hypertensive Heart Disease
    End date: 2012-06-21

Spironolactone
    Dosage: 25 mg
    Administration route: Oral
    Indication: Hypertensive Heart Disease
    End date: 2012-06-21

Other drugs received by patient: Aspirin; VI-DE 3; Calcimagon D3; Torsemide; Lantus; Allopurinol; Atorvastatin Calcium; Humalog; Marcumar



Possible Spironolactone side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: 59 year old male

Reactions: Dilatation Ventricular, Incorrect Dose Administered, Hypotension, Aortic Valve Sclerosis, Hepatic Steatosis, Colon Adenoma, Left Atrial Dilatation, Irritable Bowel Syndrome, Vision Blurred, Aortic Valve Incompetence, Hypovolaemia, Renal Failure Acute, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Furosemide
    Indication: Product Used FOR Unknown Indication

Spironolactone
    Indication: Product Used FOR Unknown Indication

Torsemide
    Indication: Product Used FOR Unknown Indication

Blinded Therapy
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25
    End date: 2011-07-08

Carvedilol
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Ezetimibe; Aspirin



Possible Spironolactone side effects in 59 year old

Reported by a physician from United States on 2012-07-23

Patient: 59 year old

Reactions: Renal Failure, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carvedilol
    Start date: 2011-05-04
    End date: 2011-05-09

Spironolactone
    Start date: 2011-05-05
    End date: 2011-05-09

Torsemide

Furosemide

Other drugs received by patient: Blinded Trial Medication; Aspirin



Possible Spironolactone side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: 59 year old male

Reactions: Hypotension, Irritable Bowel Syndrome, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Indication: Product Used FOR Unknown Indication

Carvedilol
    Indication: Product Used FOR Unknown Indication

Furosemide
    Indication: Product Used FOR Unknown Indication

Torsemide
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Ezetimibe; Aspirin; Statins; Investigational Study Drug; Anticoagulant; Fenofibrate



Possible Spironolactone side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: 59 year old male

Reactions: Aortic Valve Sclerosis, Hypotension, Condition Aggravated, Hepatic Steatosis, Irritable Bowel Syndrome, Vision Blurred, Renal Failure Acute, Hypovolaemia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torsemide
    Indication: Product Used FOR Unknown Indication

Spironolactone
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-05
    End date: 2011-05-09

Blinded Therapy
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25
    End date: 2011-07-08

Saxagliptin (Saxagliptin)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Furosemide
    Indication: Product Used FOR Unknown Indication

Carvedilol
    Indication: Product Used FOR Unknown Indication

Placebo
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Other drugs received by patient: Ezetimibe; Aspirin



Possible Spironolactone side effects in 59 year old male

Reported by a physician from United States on 2012-07-18

Patient: 59 year old male

Reactions: Hypotension, Irritable Bowel Syndrome, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Furosemide

Blinded Therapy
    Start date: 2011-09-27
    End date: 2011-12-06

Spironolactone

Carvedilol

Torsemide

Blinded Therapy
    Start date: 2011-03-25
    End date: 2011-07-08

Other drugs received by patient: Antithrombotic Agents; Ezetimibe; Aspirin; Diuretics; Cholesterol and Triglyceride Reducers; ALL Other Therapeutic Products; Antithrombotic Agents; Beta Blocking Agents; Nitroglycerin



Possible Spironolactone side effects in 85 year old male

Reported by a pharmacist from United States on 2012-06-20

Patient: 85 year old male, weighing 103.7 kg (228.1 pounds)

Reactions: Productive Cough, Hypotension, Dizziness, Condition Aggravated, Sputum Discoloured, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Dosage: 25 mg bid po
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2012-03-19
    End date: 2012-03-28

Furosemide
    Dosage: 40 mg bid po
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2010-01-22



Possible Spironolactone side effects in 81 year old male

Reported by a physician from United States on 2012-06-18

Patient: 81 year old male

Reactions: Gastrointestinal Haemorrhage, Haemorrhage, Hypotension, Anaemia, Transfusion Reaction, Osteomyelitis, Staphylococcal Sepsis, Slow Response To Stimuli, Renal Failure, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Furosemide
    Indication: Product Used FOR Unknown Indication

Insulin
    Indication: Diabetes Mellitus

Lisinopril
    Indication: Product Used FOR Unknown Indication

Allopurinol
    Indication: Product Used FOR Unknown Indication

Spironolactone
    Indication: Product Used FOR Unknown Indication

Celecoxib
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Aztreonam; Vancomycin



Possible Spironolactone side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-05

Patient: male, weighing 111.0 kg (244.2 pounds)

Reactions: Nephrolithiasis, Fatigue, Hypotension, Impaired Work Ability, Hepatic Cirrhosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Emergen-C
    Dosage: unk
    Indication: Pyrexia
    Start date: 1994-01-01

Spironolactone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Fluid Retention
    End date: 2012-05-29

Potassium Chloride
    Dosage: 20 meq, unk
    Indication: Fluid Retention
    End date: 2012-05-29

Emergen-C
    Indication: Pain



Possible Spironolactone side effects in 45 year old male

Reported by a physician on 2012-05-30

Patient: 45 year old male

Reactions: Vomiting, Nausea, Hyperkalaemia, Hyperglycaemia, Hypotension, Blood Fibrinogen Increased, Treatment Noncompliance, Hypertensive Crisis, Carotid Artery Stenosis, Renal Failure, Glycosylated Haemoglobin Increased, Fluid Intake Reduced, Vertigo, Influenza

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interrupted, frequency qd, or
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15
    End date: 2011-07-15

Aleglitazar (Aleglitazar)
    Dosage: last dose prior to hyperkalaemia: 04jul2011, dose blinded, temporarily interrupted, frequency qd, or
    Administration route: Oral
    Indication: Cardiovascular Event Prophylaxis
    Start date: 2011-02-15

Torsemide
    Dosage: 10;40 g (10;20 mg, 1 in 1;2 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-08-23

Torsemide
    Dosage: 10;40 g (10;20 mg, 1 in 1;2 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-08
    End date: 2011-05-09

Spironolactone
    Dosage: 125 mg (125 mg, 1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04
    End date: 2011-05-06

Other drugs received by patient: Clopidogrel Bisulfate; Catapressan (Clonidine Hydrochloride); Inegy (Ezetimibe, Simvasatin); Aliskiren (Aliskiren Fumarate); Hydrochlorothiazide; Nitrolingual (Nitroglycerin); Diovan; Tramabeta (Tramadol Hydrochloride); Aspirin; Nebivolol HCL; Allopurinol; Vilodagliptin (Vildagliptin); Amlodipine; Metfformin Hydrochloride; Liprogol (Lispro Insulin); Pantoprazole; Levemir; Omega-3 Acid Ethyl Esgters (Omega-3 Acid Ethyl Esters); Targin (Naloxone Hydrochloride, Oxycodone Hydrochloride)



Possible Spironolactone side effects in male

Reported by a physician from United States on 2012-05-22

Patient: male

Reactions: Hypotension, Irritable Bowel Syndrome, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carvedilol
    Indication: Product Used FOR Unknown Indication

Spironolactone
    Indication: Product Used FOR Unknown Indication
    End date: 2011-05-09

Torsemide
    Indication: Product Used FOR Unknown Indication

Blinded Saxagliptin
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25
    End date: 2011-07-08

Blinded Saxagliptin
    Start date: 2011-09-27
    End date: 2011-12-06

Furosemide
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Ezetimibe; Aspirin



Possible Spironolactone side effects in male

Reported by a physician from United States on 2012-05-17

Patient: male

Reactions: Hypotension, Irritable Bowel Syndrome, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Indication: Product Used FOR Unknown Indication
    End date: 2011-05-09

Torsemide
    Indication: Product Used FOR Unknown Indication

Blinded Saxagliptin
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Carvedilol
    Indication: Product Used FOR Unknown Indication

Furosemide
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Aspirin; Ezetimibe



Possible Spironolactone side effects in 59 year old male

Reported by a individual with unspecified qualification from United States on 2012-05-15

Patient: 59 year old male

Reactions: Dilatation Ventricular, Aortic Valve Sclerosis, Hypotension, Condition Aggravated, Hepatic Steatosis, Irritable Bowel Syndrome, Left Atrial Dilatation, Aortic Valve Incompetence, Hypovolaemia, Renal Failure Acute, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone

Carvedilol

Saxagliptin (Saxagliptin
    Dosage: (2 in 1 d)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25
    End date: 2011-07-08

Furosemide

Torsemide

Placebo
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Other drugs received by patient: Ezetimibe; Aspirin; Fibric Acid(fibric Acid)



Possible Spironolactone side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-11

Patient: 52 year old male

Reactions: Hallucination, Auditory, Hyperkalaemia, Hypotension, Bradycardia, Toxicity To Various Agents, Renal Failure Acute

Drug(s) suspected as cause:
Warfarin Sodium

Spironolactone

Isosorbide Mononitrate

Digoxin

Carvedilol

Hydralazine HCL

Furosemide

Lisinopril

Amiodarone HCL



Possible Spironolactone side effects in 82 year old female

Reported by a consumer/non-health professional from Brazil on 2012-04-18

Patient: 82 year old female

Reactions: Fluid Imbalance, Haemorrhage, Oedema Peripheral, Hypotension, Knee Arthroplasty

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine Besylate and Olmesartan Medoxomil
    Dosage: 20/5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-10-01

Diltiazem
    Dosage: 100 mg, unk
    Administration route: Oral
    End date: 2011-10-01

Spironolactone
    Dosage: unk
    Administration route: Oral
    End date: 2011-10-01

Other drugs received by patient: Pantoprazole; Levothyroxine Sodium



Possible Spironolactone side effects in 82 year old female

Reported by a consumer/non-health professional from Brazil on 2012-04-17

Patient: 82 year old female

Reactions: Fluid Imbalance, Procedural Haemorrhage, Hypotension, Oedema Peripheral, Knee Arthroplasty

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Diltiazem
    Dosage: 100 mg,per oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-10-01

Amlodipine Besylate and Olmesartan Medoxomil
    Dosage: 20/5 mg (1 in 1 d),per oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-10-01

Spironolactone
    Dosage: per oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-10-01

Other drugs received by patient: Levothyroxine Sodium; Pantoprazole (Pantoprazole) (Pantoprazole)



Possible Spironolactone side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05

Patient: 59 year old male

Reactions: Colon Adenoma, Hypotension, Dizziness, Irritable Bowel Syndrome, Renal Failure Acute, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carvedilol
    Indication: Product Used FOR Unknown Indication

Spironolactone
    Indication: Product Used FOR Unknown Indication

Furosemide
    Indication: Product Used FOR Unknown Indication

Torsemide
    Indication: Product Used FOR Unknown Indication

Blinded Therapy
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Other drugs received by patient: Aspirin; Ezetimibe



Possible Spironolactone side effects in 59 year old male

Reported by a individual with unspecified qualification from United States on 2012-04-02

Patient: 59 year old male

Reactions: Aortic Valve Sclerosis, Hypotension, Hepatic Steatosis, Vision Blurred, Irritable Bowel Syndrome, Aortic Valve Incompetence, Renal Failure Acute, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Placebo
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Spironolactone

Torsemide

Saxagliptin (Saxagliptin)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Furosemide

Carvedilol

Other drugs received by patient: Aspirin; Fibric Acid; Ezetimibe



Possible Spironolactone side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-28

Patient: 59 year old male

Reactions: Hypotension, Aortic Valve Sclerosis, Condition Aggravated, Hepatic Steatosis, Vision Blurred, Aortic Valve Incompetence, Cardiac Failure Congestive, Hypovolaemia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carvedilol
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-04
    End date: 2011-05-09

Torsemide
    Indication: Product Used FOR Unknown Indication

Spironolactone
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-05
    End date: 2011-05-09

Placebo
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Furosemide
    Indication: Product Used FOR Unknown Indication

Saxagliptin (Saxagliptin)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-25

Other drugs received by patient: Fibric Acid; Nitrates (Silver Nitrate); Beta-Blocker (Beta Blocking Agents); Aspirin; Statin Oral Anticoagulants; Ezetimibe; Diuretics (Diuretics); Anti-Platelet Agents (Platelet Aggregation Inhbiitors Excl.heparin_



Possible Spironolactone side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-27

Patient: 59 year old male

Reactions: Dilatation Ventricular, Hypotension, Aortic Valve Sclerosis, Condition Aggravated, Hepatic Steatosis, Vision Blurred, Left Atrial Dilatation, Aortic Valve Incompetence, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Furosemide

Saxagliptin (Saxagliptin)
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Spironolactone

Placebo
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-03-25

Torsemide

Carvedilol

Other drugs received by patient: Ezetimibe; Aspirin



Possible Spironolactone side effects in 74 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26

Patient: 74 year old male, weighing 81.2 kg (178.6 pounds)

Reactions: Excoriation, Anaemia, Hypotension, Neutropenic Sepsis, Tachycardia, Mental Status Changes, Atrial Fibrillation, Pyrexia, Fall, Cardiac Failure, Diarrhoea, Neutropenia, Cardiac Arrest, Lethargy, Cough

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisone
    Administration route: Oral
    Start date: 2012-02-02
    End date: 2012-02-15

Lasix
    Indication: Cardiac Disorder
    End date: 2012-02-22

Matulane
    Administration route: Oral
    Start date: 2012-02-02
    End date: 2012-02-15

Spironolactone
    Indication: Cardiac Disorder
    End date: 2012-02-22

Coreg
    Indication: Cardiac Disorder
    End date: 2012-02-22

Cytoxan
    Start date: 2012-02-09
    End date: 2012-02-16

Lisinopril
    Indication: Cardiac Disorder
    End date: 2012-02-22

Vinblastine Sulfate
    Start date: 2012-02-09
    End date: 2012-02-16

Other drugs received by patient: Levofloxacin; Prevacid; Tamsulosin HCL; Klor-CON; Folic Acid; Multi-Vitamins; Bleomycin Sulfate; Dacarbazine; Lidocaine; Zofran; Doxorubicin HCL



Possible Spironolactone side effects in male

Reported by a physician from United States on 2012-03-23

Patient: male, weighing 87.3 kg (192.1 pounds)

Reactions: Dehydration, Hypotension, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Enalapril Maleate
    Dosage: unk
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    Start date: 2012-02-16
    End date: 2012-03-05

Spironolactone
    Dosage: 50 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2006-12-15

Spironolactone
    Indication: Hypertension

Coreg
    Dosage: 3.125 mg, bid
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2012-01-11

Bumex
    Indication: Hypertension

Blinded NO Treatment Received
    Dosage: unk
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    Start date: 2012-02-16
    End date: 2012-03-05

Valsartan
    Dosage: unk
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    Start date: 2012-02-16
    End date: 2012-03-05

Bumex
    Dosage: 0.5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-12-20

Other drugs received by patient: Aspirin



Possible Spironolactone side effects in 59 year old

Reported by a physician from United States on 2012-03-22

Patient: 59 year old

Reactions: Renal Failure, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Start date: 2011-05-05
    End date: 2011-05-09

Carvedilol
    Start date: 2011-05-04
    End date: 2011-05-09

Furosemide

Torsemide

Other drugs received by patient: Aspirin; Blinded Trial Medication



Possible Spironolactone side effects in female

Reported by a physician from United States on 2012-03-06

Patient: female, weighing 48.1 kg (105.8 pounds)

Reactions: Cardiac Failure, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Furosemide
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2009-03-04

Ritonavir
    Dosage: 100 mg, 2x/day
    Start date: 2009-09-01

Raltegravir
    Dosage: 400 mb, bid
    Start date: 2009-09-02

Darunavir
    Dosage: 600 mg, od
    Administration route: Oral
    Start date: 2009-09-01

Truvada
    Dosage: 1 df, 1x/day
    Start date: 2011-09-24

Spironolactone
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-05-09

Maraviroc
    Dosage: 300 mg, 2x/day
    Start date: 2009-12-28

Furosemide
    Indication: Cardiac Failure Chronic

Other drugs received by patient: Digoxin; Carvedilol; Albuterol; Losartan; Digoxin; Glimepiride; Acetaminophen and Hydrocodone Bitartrate; Guaifenesin



Possible Spironolactone side effects in female

Reported by a physician from United States on 2012-03-01

Patient: female, weighing 48.1 kg (105.8 pounds)

Reactions: Cardiac Failure, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Raltegravir
    Dosage: 400 mb, bid
    Start date: 2009-09-02

Furosemide
    Indication: Cardiac Failure Chronic

Darunavir
    Dosage: 600 mg, od
    Administration route: Oral
    Start date: 2009-09-01

Ritonavir
    Dosage: 100 mg, 2x/day
    Start date: 2009-09-01

Maraviroc
    Dosage: 300 mg, 2x/day
    Start date: 2009-12-28

Furosemide
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2009-03-04

Spironolactone
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-05-09

Truvada
    Dosage: 1 df, 1x/day
    Start date: 2011-09-24

Other drugs received by patient: Guaifenesin; Digoxin; Albuterol; Digoxin; Acetaminophen and Hydrocodone Bitartrate; Carvedilol; Losartan; Glimepiride



Possible Spironolactone side effects in 75 year old male

Reported by a physician from Norway on 2012-02-23

Patient: 75 year old male

Reactions: Peripheral Coldness, Confusional State, Metabolic Acidosis, Hyperkalaemia, Hypotension, Pulmonary Embolism, Bundle Branch Block Left, General Physical Health Deterioration, Drug Interaction, Cardiogenic Shock, Haemodialysis, Bradycardia, Septic Shock, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ramipril
    Dosage: 10 mg (10 mg, 1 in 1 d)
    Indication: Cardiac Failure

Metoprolol Tartrate
    Dosage: 100 mg (100 mg, 1 in d)
    Indication: Cardiac Failure

Spironolactone
    Dosage: 25 mg (25 mg, 1 in1 d)
    Indication: Cardiac Failure

Other drugs received by patient: Bumetanid (Bumetanide); Digitoxin TAB



Possible Spironolactone side effects in male

Reported by a physician from Sweden on 2012-02-17

Patient: male

Reactions: Confusional State, Hyperkalaemia, Hypotension, Muscle Spasms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Administration route: Oral
    Indication: Cardiac Disorder
    Start date: 2011-12-08

Atacand
    Administration route: Oral
    Indication: Cardiac Disorder
    Start date: 2011-12-15
    End date: 2011-12-28

Other drugs received by patient: Allopurinol; Suscard; Humalog; Dimor; Bisoprolol Fumarate; Levemir; Hydroxocobalamin; Levothyroxine Sodium; Oxazepam; Furosemide; Cipralex; Nitrolingual



Possible Spironolactone side effects in 64 year old male

Reported by a pharmacist from United States on 2012-02-14

Patient: 64 year old male, weighing 89.7 kg (197.3 pounds)

Reactions: Vomiting, Hyperkalaemia, Dehydration, Hypophagia, Hypotension, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Lisinopril
    Dosage: mg po
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-01-26
    End date: 2012-01-27

Lisinopril
    Dosage: mg po
    Administration route: Oral
    Indication: Cardiac Failure Congestive
    Start date: 2010-01-26
    End date: 2012-01-27

Spironolactone
    Dosage: mg po
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2010-01-26
    End date: 2012-01-27

Spironolactone
    Dosage: mg po
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-01-26
    End date: 2012-01-27



Possible Spironolactone side effects in female

Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-02-10

Patient: female

Reactions: Head Injury, Hypotension, Brain Contusion, Fall, Cerebral Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Altace
    Dosage: 1.2 mg, 1x/day
    Administration route: Oral
    Indication: Myocardial Ischaemia
    End date: 2009-09-17

Spironolactone
    Dosage: unk
    End date: 2009-09-17

Other drugs received by patient: Aspirin; Plavix; Metoprolol Tartrate; Risperdal; Simvastatin; Propavan



Possible Spironolactone side effects in 75 year old male

Reported by a physician from Norway on 2012-02-07

Patient: 75 year old male

Reactions: Confusional State, Peripheral Coldness, Ventricular Hypokinesia, Hyperkalaemia, Electrocardiogram T Wave Abnormal, Hypovolaemia, Metabolic Acidosis, Hypotension, Heart Valve Incompetence, General Physical Health Deterioration, Electrocardiogram QRS Complex Abnormal, Cardiogenic Shock, Cardiac Output Decreased, Renal Failure, Heart Rate Decreased, Ejection Fraction Decreased, Oliguria, Bradycardia, Altered State of Consciousness, Electrocardiogram P Wave Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Metoprolol
    Dosage: 100 mg, qam
    Indication: Cardiac Failure

Digoxin
    Dosage: 50 mcg, qam
    Indication: Cardiac Failure

Bumetanide
    Dosage: 1.5 mg, qam
    Indication: Cardiac Failure

Ramipril
    Dosage: 10 mg, qam

Spironolactone
    Dosage: 25 mg, qam



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017